Do Not Do Recommendation

 

Do not continue treatment with tamoxifen or raloxifene beyond 5 years for chemoprevention in women with no personal history of breast cancer

Do Not Do Recommendation Details

Recommendation:

Do not continue treatment with tamoxifen or raloxifene beyond 5 years for chemoprevention in women with no personal history of breast cancer

Interventions:
tamoxifen or raloxifene

Source guidance details

Guidance:
Familial breast cancer: NICE guidance (CG164)
Published date:
June 2013
Paragraph number:
1.7.28
Page number:
34

View all NICE do not do from this Guidance